Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Register your company now
P-LLY PP-ZP-US-0986 08/2024 Lilly Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including statements about the supply and access of Zepbound (tirzepatide) as a treatment for adults with obesity or overweight and reflects Lilly's current belief and expectations
One Wegovy trial on people with overweight and obesity found that people lost an average of about 15 percent of their body weight in under 16 months
Does dysesthesia affect: Manual dexterity (typing, writing, fine motor tasks)
Under proper storage conditions, an unopened bacteriostatic water vial will remain stable until its printed expiration date
US$ 26.45
US$ 28.99
US$ 24.77
US$ 28.59
